Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | PAB1-binding protein , putative | 0.0028 | 0.0418 | 1 |
Brugia malayi | hypothetical protein | 0.0039 | 0.0897 | 0.0897 |
Loa Loa (eye worm) | hypothetical protein | 0.0181 | 0.6637 | 0.6637 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0028 | 0.0418 | 1 |
Echinococcus granulosus | geminin | 0.0186 | 0.6833 | 0.9984 |
Brugia malayi | hypothetical protein | 0.0018 | 0.0021 | 0.0021 |
Schistosoma mansoni | hypothetical protein | 0.0039 | 0.0897 | 0.1313 |
Echinococcus multilocularis | jun protein | 0.0186 | 0.6844 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0028 | 0.0418 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0186 | 0.6844 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0028 | 0.0418 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0028 | 0.0418 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0028 | 0.0418 | 1 |
Brugia malayi | hypothetical protein | 0.0028 | 0.0418 | 0.0418 |
Brugia malayi | MH2 domain containing protein | 0.0131 | 0.4606 | 0.4606 |
Schistosoma mansoni | hypothetical protein | 0.0151 | 0.543 | 0.7947 |
Brugia malayi | bZIP transcription factor family protein | 0.0186 | 0.6844 | 0.6844 |
Brugia malayi | hypothetical protein | 0.0146 | 0.5223 | 0.5223 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.6833 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.6833 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.0897 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0186 | 0.6844 | 1 |
Schistosoma mansoni | jun-related protein | 0.0151 | 0.543 | 0.7947 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0028 | 0.0418 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0028 | 0.0418 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0039 | 0.0897 | 0.1311 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.0897 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0039 | 0.0897 | 0.1311 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0131 | 0.4606 | 0.4606 |
Echinococcus granulosus | jun protein | 0.0186 | 0.6844 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.0897 | 0.5 |
Onchocerca volvulus | 0.0264 | 1 | 1 | |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0131 | 0.4606 | 0.4606 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0017 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0418 | 0.0418 |
Echinococcus multilocularis | geminin | 0.0186 | 0.6833 | 0.9984 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0264 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.0897 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0039 | 0.0897 | 0.1313 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 25 % | Evaluation for percent inhibition of prostaglandin G/H synthase 2 in human whole blood (HWB) at a concentration of 1 um | ChEMBL. | 15084117 |
Inhibition (binding) | = 25 % | Evaluation for percent inhibition of prostaglandin G/H synthase 2 in human whole blood (HWB) at a concentration of 1 um | ChEMBL. | 15084117 |
Inhibition (binding) | = 50 % | Percentage inhibition of prostaglandin G/H synthase 1 in human whole blood (HWB) at a concentration of 100 um | ChEMBL. | 15084117 |
Inhibition (binding) | = 50 % | Percentage inhibition of prostaglandin G/H synthase 1 in human whole blood (HWB) at a concentration of 100 um | ChEMBL. | 15084117 |
Inhibition (binding) | = 85 % | Evaluation for percent inhibition of prostaglandin G/H synthase 2 in human whole blood (HWB) at a concentration of 10 um | ChEMBL. | 15084117 |
Inhibition (binding) | = 85 % | Evaluation for percent inhibition of prostaglandin G/H synthase 2 in human whole blood (HWB) at a concentration of 10 um | ChEMBL. | 15084117 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.